# NYPOZI
> **BLA761126** · Biologics License Application · Sponsor: TANVEX BIOPHARMA USA INC · Approved 2024-06-28
## Drug
- **FDA Application Number:** BLA761126
- **Application type:** Biologics License Application
- **Brand name:** NYPOZI
- **Generic name:** FILGRASTIM-TXID
- **Active ingredients:** FILGRASTIM-TXID
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** TANVEX BIOPHARMA USA INC
- **Manufacturer:** Tanvex BioPharma USA, Inc.
- **First approval:** 2024-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761126)
---
*AI Analytics · CC0 1.0*